Allogene Therapeutics, Inc. earnings per share and revenue

ALLO earnings per share for the last quarter are -0.28 USD whereas the estimation was -0.33 USD which accounts for 14.25% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 9.14 k USD. Estimated earnings per share for the next quarter are -0.29 USD, and revenue is expected to reach 2.00 k USD. Also watch annual changes over time to get a bigger picture of ALLO earnings per share and revenue dynamics.